A phase II trial of exemestane and ruxolitinib for aI-resistant ER plus breast cancer: Interim safety, efficacy, and biomarker analysis Meeting Abstract
| Authors: | DeMichelel, A. M.; Colameco, C. B.; Kalota, A.; Troxel, A. B.; Holmes, R.; Cimildoro, R.; Zafman, K.; Fox, K. R.; Domchek, S. M.; Gogineni, K.; Bradbury, A. R.; Matro, J. M.; Shih, N.; Feldman, M. D.; Clark, A. S.; Hexner, E. O.; Bromberg, J. F. |
| Abstract Title: | A phase II trial of exemestane and ruxolitinib for aI-resistant ER plus breast cancer: Interim safety, efficacy, and biomarker analysis |
| Meeting Title: | 106th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 75 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 Apr 18-22 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2015-08-01 |
| Language: | English |
| ACCESSION: | WOS:000371597100012 |
| DOI: | 10.1158/1538-7445.am2015-ct114 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: CT114 -- 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR) -- APR 18-22, 2015 -- Philadelphia, PA -- Source: Wos |
